Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy

BACKGROUND: Autologous anti‐CD19 chimeric antigen receptor (CAR) T‐cell therapy is an effective treatment for approximately 40% of relapsed/refractory large B cell lymphomas (LBCL), and early identification of patients at risk for relapse or progression after CAR T‐cell therapy represents a clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Guidetti, Anna, Dodero, Anna, Lorenzoni, Alice, Pizzamiglio, Sara, Argiroffi, Giovanni, Chiappella, Annalisa, Bagnoli, Filippo, Marasco, Vincenzo, Carniti, Cristiana, Monfrini, Chiara, Seregni, Ettore, Pennisi, Martina, Verderio, Paolo, Alessi, Alessandra, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099560/
https://www.ncbi.nlm.nih.gov/pubmed/36385707
http://dx.doi.org/10.1002/cncr.34532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099560/
https://www.ncbi.nlm.nih.gov/pubmed/36385707
http://dx.doi.org/10.1002/cncr.34532

Ejemplares similares